B. Bourbigot

2.0k citations

33 papers · 1.3k indexed · h-index 16

Impact in

Transplantation top 0.5%
- Renal Transplantation Outcomes and Treatments
Psychiatry and Mental health top 5%
- Neurological Complications and Syndromes

Papers in ⓘ

Transplantation 17
- Renal Transplantation Outcomes and Treatments 17
Psychiatry and Mental health 11
- Neurological Complications and Syndromes 10

Co-authors: Josette Eris (3 shared papers)Scott B. Campbell (3 shared papers)Š Vı́tko (3 shared papers)Pierre Quartier (1 shared paper)C. Antoine (1 shared paper)J. L. Garnier (1 shared paper)Anne‐Sophie Carret (1 shared paper)V. Leblond (1 shared paper)
Journals: Transplantation (6 papers)Transplant International (4 papers)American Journal of Transplantation (2 papers)Clinical Transplantation (2 papers)Nephrology Dialysis Transplantation (1 paper)
Partner nations: France United States Switzerland

In The Last Decade

B. Bourbigot

33 papers receiving 1.2k citations

Peers

Countries citing papers authored by B. Bourbigot

Since Specialization

Citations

This map shows the geographic impact of B. Bourbigot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Bourbigot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Bourbigot more than expected).

Fields of papers citing papers by B. Bourbigot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Bourbigot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Bourbigot. The network helps show where B. Bourbigot may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Bourbigot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Bourbigot Line = papers co-authored together B. Bourbigot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients Annals of Oncology ·Nöel Milpied, B. Vasseur, Nathalie Parquet, J. L. Garnier, C. Antoine, Pierre Quartier, Anne‐Sophie Carret, Didier Bouscary, Albert Faye, B. Bourbigot, Yves Réguerre, A.-M. Stoppa, Pascal Bourquard, Bruno Hurault de Ligny, F. Dubief, A. Mathieu-Boué, V. Leblond	2000	285
2	Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies American Journal of Transplantation ·Š Vı́tko, Hélio Tedesco‐Silva, Josette Eris, Julio Pascual, John Whelchel, John C. Magee, Scott B. Campbell, G Civati, B. Bourbigot, Gentil Alves Filho, John P. Leone, Valter Duro Garcı́a, Paolo Rigotti, Ronaldo Esmeraldo, V. Cambi, T Haas, Annette Jappe, Peter Bernhardt, Johanna Geissler, Nathalie Cretin	2004	207
3	Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12 Transplantation ·Joseph Lawen, Elizabeth Davies, Georges Mourad, F. Oppenheimer, M. González Molina, Lionel Rostaing, Alan Wilkinson, Laura L. Mulloy, B. Bourbigot, H. Prestele, Alexander Korn, Dani le Girault	2003	113
4	DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS1 Transplantation ·John M. Kovarik, P. Wolf, J.M. Cisterne, G. Mourad, Yvon Lebranchu, P Lang, B. Bourbigot, Diego Cantarovich, Dominique Girault, Christophe Gerbeau, Arne Schmidt, J.P. Soulillou	1997	99
5	12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients Transplant International ·Hélio Tedesco‐Silva, Š Vı́tko, Julio Pascual, Josette Eris, John C. Magee, John Whelchel, G Civati, Scott B. Campbell, G. Alves-Filho, B. Bourbigot, Valter Duro Garcı́a, John P. Leone, Ronaldo Esmeraldo, Paolo Rigotti, V. Cambi, T Haas, (unknown)	2006	88
6	Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids Transplantation ·Denis Glotz, Bernard Charpentier, Daniel Abramovicz, Philippe Lang, Lionel Rostaing, Gérard Rifle, Yves Vanrenterghem, F. Berthoux, B. Bourbigot, Michel Delahousse, Jean‐Marc Chalopin, Élisabeth Cassuto, N Lefrançois	2010	50
7	Impact of Cyclosporine Reduction With MMF: A Randomized Trial in Chronic Allograft Dysfunction. The ‘Reference’ Study American Journal of Transplantation ·Luc Frimat, E. Cassuto‐Viguier, B Charpentier, C. Noël, François Provôt, L. Rostaing, Denis Glotz, J D Sraer, B. Bourbigot, Bruno Moulin, Philippe Lang, (unknown), Claire Pouteil‐Noble, S. Girardot-Seguin, M. Kessler	2006	48
8	Graft Function, Cardiovascular Risk Factors, and Sex Hormones in Renal Transplant Recipients on an Immunosuppressive Regimen of Everolimus, Reduced Dose of Cyclosporine, and Basiliximab Transplantation Proceedings ·Bernhard K. Krämer, H. H. Neumayer, R. Stahl, M Pietrzyk, B. Krüger, Benjamin Pfalzer, B. Bourbigot, Scott B. Campbell, J. Whelchel, Josette Eris, Š Vı́tko, Klemens Budde	2005	41
9	High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients. PubMed ·Ronan S. Tanneau, Alastair Henry, F Rouhart, B. Bourbigot, B. Garo, Yves Mocquard, J Y Goas	1994	40
10	Zygomycosis caused byCunninghamella bertholletiaein a kidney transplant recipient Medical Mycology ·Dorothée Quinio, A. Karam, Jordan Leroy, M.-C. Moal, B. Bourbigot, O. Masure, B. Sassolas, A.-M. Le Flohic	2004	38
11	Captopril induces correction of postrenal transplant erythremia Transplant International ·Mohammad Shohidul Islam, B. Bourbigot, Jean-Pierre Codet, B. Songy, Georges Fournier, J Clèdes	1990	32
12	Toxoplasmosis-associated hemophagocytic syndrome in renal transplantation Transplant International ·Liviu Segall, Marie‐Christine Moal, Laurent Doucet, Nathalie Kergoat, B. Bourbigot	2005	25
13	PROSPECTIVE RANDOMIZED COMPARISON OF UNIVERSITY OF WISCONSIN AND UW-MODIFIED, LACKING HYDROXYETHYL-STARCH, COLD-STORAGE SOLUTIONS IN KIDNEY TRANSPLANTATION Transplantation ·R. Baatard, F. Pradier, Jacques Dantal, Georges Karam, Diego Cantarovich, Maryvonne Hourmant, B. Bourbigot, Jean‐Paul Soulillou	1993	21
14	Captopril induces correction of postrenal transplant erythremia Transplant International ·Mohammad Shohidul Islam, B. Bourbigot, Jean-Pierre Codet, B. Songy, Georges Fournier, J Clèdes	1990	19
15	EFFECTS OF MHC-ENCODED TAP1 AND TAP2 GENE POLYMORPHISM AND MATCHING ON KIDNEY GRAFT REJECTION Transplantation ·Dominique Chevrier, Magali Giral, Véronique M. Braud, B. Bourbigot, Jean Muller, J. Bignon, Jean Paul Soulillou	1995	17
16	Recurrent Hematuria in 4 White Patients with Sickle Cell Trait The Journal of Urology ·Éric Oksenhendler, B. Bourbigot, François Desbazeille, D Droz, Christian Choquenet, Robert Girot, Paul Jungers	1984	15
17	Conversion to Enteric-Coated Mycophenolate Sodium From Various Doses of Mycophenolate Mofetil: Results of a Prospective International Multicenter Trial in Maintenance Renal Transplant Patients Receiving Cyclosporine Transplantation Proceedings ·Björn Nashan, Barbara Suwelack, Katrin Ivens, Wolfgang Arns, Karl Lhotta, B. Bourbigot, Klemens Budde, Wolfgang Fischer, Frank Pietruck	2006	14
18	Efficacy and safety of enteric‐coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials Clinical Transplantation ·Frank Pietruck, Klemens Budde, Maurizio Salvadori, Hans W. Sollinger, B. Bourbigot, M.A. Gentil, F. Oppenheimer	2006	13
19	CD4 T-lymphocyte counts as predictors of pneumonia after kidney transplantation. PubMed ·B. Bourbigot, T. A. Bensoussan, B. Garo, Md. Shahidul Islam, E Hardy, Marie‐Christine Moal, M Garré	1993	12
20	BASILIXIMAB (SIMULECT®) IS SAFE AND EFFECTIVE IN COMBINATION WITH TRIPLE THERAPY OF NEORAL®, STEROIDS AND CELLCEPT® IN RENAL TRANSPLANT RECIPIENTS. Transplantation ·Joseph Lawen, E.A. Davies, G. Mourad, F Oppenheimer, M. González-Molina, B. Bourbigot, D Durand, Laura Mulloy, Alexander Wilkinson, Dominique Girault	2000	11

About B. Bourbigot

B. Bourbigot is a scholar working on Transplantation, Psychiatry and Mental health, Hematology, Hepatology and Genetics, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (17 papers), Neurological Complications and Syndromes (10 papers), Pharmacological Effects and Toxicity Studies (6 papers), Cytomegalovirus and herpesvirus research (5 papers), Hemoglobinopathies and Related Disorders (4 papers), Organ Transplantation Techniques and Outcomes (4 papers), Erythropoietin and Anemia Treatment (3 papers) and Polyomavirus and related diseases (3 papers). The work is most often cited by research in Transplantation (659 citations), Psychiatry and Mental health (200 citations), Oncology (344 citations), Physiology (45 citations) and Hematology (108 citations). B. Bourbigot has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Josette Eris, Scott B. Campbell, Š Vı́tko, Pierre Quartier, C. Antoine, J. L. Garnier, Anne‐Sophie Carret, V. Leblond, A.-M. Stoppa and Nöel Milpied. Their work appears in journals such as Transplantation, Transplant International, American Journal of Transplantation, Clinical Transplantation and Nephrology Dialysis Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact